For adults with type 2 diabetes mellitus (T2DM), bofanglutide, a glucagon-like peptide-1 receptor agonist, is associated with meaningful reductions in hemoglobin A1C (HbA1c) levels compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results